文献速递前列腺癌

磁共振成像用于长期主动监测中的活检决策

Magnetic resonance imaging for long-term active surveillance biopsy decision-making.
PubMed 文献 · BJU Int · 2025-05-29

单中心主动监测队列中221例GG1前列腺癌患者接受6年MRI和活检,22%重新分级为GG≥2;PSA密度和PI-RADS 4-5是显著预测因素,既往阴性活检与GG≥2负相关;单独不活检遗漏GG≥2风险为12%,联合既往阴性活检和PSA密度<0.10 ng/mL/cc时风险最低为5.3%。

要点

  • 6年MRI不 suspicious(PI-RADS 1-2)单独不足以安全省略6年活检,遗漏GG≥2风险12%。
  • PSA密度和PI-RADS 4-5是GG≥2的显著预测因素,既往阴性活检与GG≥2负相关。
  • 联合MRI、PSA密度和既往活检状态可个体化调整监测强度,但需更大队列验证。

核心结论

  • 6年时MRI不 suspicious 单独不足以按现行指南省略6年主动监测活检。
  • 联合MRI findings、PSA密度和既往阴性活检是调整监测强度的有前景策略。
  • 研究结果需在更大队列中重复验证后方可临床实施。

研究设计与样本

  • 单中心主动监测队列分析,纳入GG1前列腺癌患者221例,均接受 scheduled 6年MRI和活检。
  • 采用多变量logistic回归检验PI-RADS评分、PSA密度、既往活检状态与重新分级至GG≥2的关联。
  • 分析基于显著预测因素避免6年活检时会遗漏多少GG≥2癌症。

主要发现

  • 221例中49例(22%)重新分级为GG≥2。
  • PSA密度和PI-RADS 4-5是GG≥2的显著预测因素;既往阴性AS活检与GG≥2负相关。
  • MRI不 suspicious(PI-RADS 1-2)时省略6年活检遗漏GG≥2的风险为12%(95%CI 5.3-19%)。
  • 既往阴性活检且PSA密度<0.10 ng/mL/cc的患者GG≥2风险最低,为5.3%(95%CI 1.5-10%)。

关键数值与推荐

  • GG≥2重新分级总体发生率22%(49/221)。
  • MRI不 suspicious(PI-RADS 1-2)省略活检遗漏GG≥2风险12%(95%CI 5.3-19%)。
  • 既往阴性活检且PSA密度<0.10 ng/mL/cc时GG≥2风险5.3%(95%CI 1.5-10%)。

临床怎么用

  • 6年时MRI不 suspicious 不应单独作为省略活检的依据。
  • 可结合PSA密度和既往活检状态评估省略6年活检的风险,尤其既往阴性且PSA密度<0.10 ng/mL/cc者风险较低。
  • 联合策略需在更大队列验证后再用于临床决策。

局限性

  • 单中心队列分析,结果需在更大队列中重复验证。
  • 研究为观察性分析,未报告外部验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate whether long-term magnetic resonance imaging (MRI) findings, alone or in combination with prostate-specific antigen (PSA) density or the result of prior surveillance biopsies, could be used to omit biopsies occurring after patients have been on active surveillance (AS) for ≥5 years. PATIENTS AND METHODS: Analysis of a single-institution AS cohort of patients with Grade Group (GG) 1 prostate cancer who underwent a scheduled 6-year MRI and biopsy. Multivariable logistic regression was used to test the association between the Prostate Imaging-Reporting and Data System (PI-RADS) score, PSA density, status of prior AS biopsy, and reclassification to GG ≥2. We then analysed how many GG ≥2 cancers would be missed if the 6-year biopsy was avoided based on significant predictors. RESULTS: In all, 49 of 221 men (22%) were reclassified to GG ≥2. PSA density and PI-RADS scores 4-5 were significant predictors; a prior negative AS biopsy was inversely associated with GG ≥2. The risk of missing GG ≥2 if the 6-year biopsy is omitted in men with an unsuspicious MRI (PI-RADS 1-2) was 12% (95% confidence interval [CI] 5.3-19%). After testing combinations of MRI findings, PSA density, and the status of the prior biopsy, we found the lowest risk of GG ≥2 in patients with a prior negative biopsy and PSA density of <0.10 ng/mL/cc (5.3%, 95% CI 1.5-10%). CONCLUSIONS: An unsuspicious MRI at 6 years is not enough alone to omit the 6-year AS biopsy under current guidelines. Combining MRI findings, PSA density, and prior negative AS biopsies is a promising strategy to tailor surveillance intensity. Our findings should be replicated in larger cohorts prior to implementation in clinical practice.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Leni R, Tin AL, Liso N, et al. Magnetic resonance imaging for long-term active surveillance biopsy decision-making. BJU Int. 2025. PMID: 40437977. doi:10.1111/bju.16798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。